Vascular Dynamics Inc. (VDI), a private company, said the FDA has approved an IDE application to initiate a pivotal trial for the Mobiushd system in the treatment of resistant hypertension. The Controlling and Lowering Blood Pressure with Mobiushd (CALM) 2 trial is a multicenter, prospective, randomized, double-blind, sham-controlled pivotal study.